Peer-Reviewed Papers
Explore published research on mitochondrial function, cellular energy, (-)-epicatechin,
vascular biology, and related metabolic pathways. Browse by specialization below to quickly
find the papers most relevant to your interests.
Search Papers by Specialization
(−)-Epicatechin and Mitochondrial Function
Study Title: Effects of (−)-epicatechin on mitochondria
Citation: Daussin FN, et al. (2021) Nutrition Reviews
What the Study Found: This review summarizes research on (−)-epicatechin and mitochondrial biology. The authors discuss evidence that (−)-epicatechin may influence mitochondrial content, respiration, antioxidant defenses, calcium handling, and biogenesis signaling.
Much of the evidence comes from cell, animal, and mechanistic studies, with some human research in specific populations. Key pathways discussed include nitric oxide signaling, SIRT1, PGC-1α, TFAM, and oxidative metabolism.
Clinical Relevance: Evidence type: review article. This paper organizes existing research rather than reporting one new clinical trial. The findings support continued interest in (−)-epicatechin and mitochondrial function, but they should not be used to claim that Mitozz treats disease or directly improves human outcomes.
What this means in real life: Mitochondria help cells produce energy and respond to stress. This review suggests that (−)-epicatechin is relevant to mitochondrial research, especially around cellular energy, oxidative stress balance, and mitochondrial biogenesis.
Related Content:
- Want to understand what “mitochondrial support” means in the Mitozz context? → Mitozz, (-)-Epicatechin and “Mitochondrial Support
- Want to understand how (−)-epicatechin connects to mitochondrial adaptation? → (-)-Epicatechin and Mitochondrial Health: What the Science Suggests
- Want to understand mitochondrial biogenesis and quality control? →Mitochondrial Biogenesis and Mitophagy: Build More, Clear Better
Epicatechin Extended Lifespan in Male Mice
Study Title: Extension of lifespan by epicatechin, halofuginone and mitoglitazone in male but not female genetically heterogeneous mice
Citation: Strong et al., 2025, Springer Nature.
Tags:
Mitozz, (−)-epicatechin, healthy aging, longevity
What the Study Found:
This controlled animal study tested dietary epicatechin in genetically diverse male and female mice at three research sites.
Male mice receiving epicatechin had a modest increase in median lifespan. Female mice did not show a significant lifespan benefit.
The study did not directly measure mitochondrial function, ATP production, or the biological reason for the male-specific result.
Clinical Relevance:
This was a mouse study, not a human clinical trial. It does not show that epicatechin, cocoa flavanols, dark chocolate, or Mitozz extends human lifespan.
What this means in real life:
The finding adds to preclinical research on epicatechin and aging biology. However, it is not evidence that people will experience the same effect.
More human research is needed to understand dose, safety, mechanisms, and whether any lifespan-related effects translate beyond animal models.
Related Content:
- Want to understand epicatechin and mitochondrial research? → Mitozz, (-)-Epicatechin and “Mitochondrial Support”
- Want to explore the broader science? → (-)-Epicatechin and Mitochondrial Health: What the Science Suggests
- Want to learn about practical mitochondrial-health foundations? → How to Repair and Maintain Mitochondrial Health Naturally
Dietary Epicatechin and Survival in Diabetic Mice, A Preclinical Study
Study Title:
Dietary Epicatechin Promotes Survival of Obese Diabetic Mice and Drosophila melanogaster
Citation:
Si H, Et al. Dietary Epicatechin Promotes Survival of Obese Diabetic Mice and Drosophila melanogaster. The Journal of Nutrition.
What the Study Found:
This animal study examined epicatechin in obese diabetic mice and fruit flies. Diabetic mice received epicatechin in drinking water for 15 weeks.
At 20 weeks of age, survival was higher in epicatechin-treated mice than untreated mice. The treated mice also showed changes in inflammatory, cholesterol, liver, vascular, and skeletal-muscle measures.
Epicatechin did not significantly change blood glucose, food intake, body-weight gain, or blood pressure in the diabetic mice. In fruit flies, several epicatechin doses were associated with longer mean lifespan.
Clinical Relevance:
This was a preclinical study in animals, not a human clinical trial. It does not show that epicatechin improves lifespan, blood sugar control, or disease outcomes in people.
What this means in real life:
The findings are relevant to research on metabolic stress, inflammation, oxidative stress, muscle function, and cellular-energy signaling.
However, the mice remained severely hyperglycemic, and the researchers did not directly measure mitochondrial function, ATP production, or mitochondrial biogenesis.
Related Content:
- Want to understand how metabolic stress and body weight can relate to cellular energy? → Mitochondrial Dysfunction and Obesity: What’s the Connection?
- Want to explore how inflammation and mitochondrial signaling can interact? → Mitochondria and Inflammation: The Two-Way Connection
- Want to learn how mitochondrial renewal and quality control work together? → Mitochondrial Biogenesis and Mitophagy: Build More, Clear Better
Epicatechin Activates Nrf2 and Cell Signaling Pathways in HepG2 Cells
Study Title: Epicatechin induces NF-κB, activator protein-1 (AP-1) and nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) via phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and extracellular regulated kinase (ERK) signalling in HepG2 cells
Citation: Granado-Serrano et al., 2010 · British Journal of Nutrition
What the Study Found: This laboratory study examined how epicatechin affects stress-response signaling in HepG2 cells, a human liver-derived cell line. The researchers found that epicatechin activated several transcription factors involved in cellular stress and antioxidant-response biology, including NF-κB, AP-1, and Nrf2.
The authors reported that these effects involved PI3K/AKT and ERK signaling pathways. Overall, the study suggests that epicatechin may influence how liver-derived cells respond to oxidative and cellular stress, but these findings were observed in a controlled cell-culture model, not in humans.
What this means in real life: This paper helps explain a possible mechanism behind epicatechin’s biological activity. Rather than acting only as a direct antioxidant, epicatechin may also interact with internal cell-signaling systems that regulate stress response and antioxidant defenses.
Because this was a cell study, it does not prove that epicatechin improves liver function, reduces inflammation, or treats oxidative stress in people. It is best understood as early mechanistic evidence that may help guide future research.
Clinical Relevance: Cell/laboratory study using HepG2 cells; epicatechin, NF-κB, AP-1, Nrf2, PI3K/AKT, ERK signaling, oxidative stress biology, and liver-cell signaling pathways; not an animal study, not a human clinical trial, and not evidence of disease treatment or clinical benefit.
Related Content:
- For a deeper look at epicatechin and mitochondrial support → Mitozz, (-)-Epicatechin and “Mitochondrial Support”
- For a broader explanation of oxidative stress and cellular energy → What Does “Mitochondrial Dysfunction” Actually Feel Like?
- For a practical explanation of mitochondrial renewal and cellular quality control → Mitochondrial Biogenesis and Mitophagy: Build More, Clear Better
Human Pharmacokinetic Study of Purified (−)-Epicatechin
Study Title: Pharmacokinetic, partial pharmacodynamic and initial safety analysis of (−)-epicatechin in healthy volunteers
Citation: Barnett et al., 2015 · Food & Function
What the Study Found: This phase I, open-label human study evaluated purified (−)-epicatechin in healthy volunteers. Participants received single oral doses of 50, 100, or 200 mg, or repeated 50 mg doses once or twice daily for 5 days. The researchers measured absorption, metabolism, early safety, and selected biological markers related to nitric oxide signaling, mitochondrial enzyme activity, and muscle-related pathways.
The authors reported that purified (−)-epicatechin was rapidly absorbed and metabolized, with several metabolites detected in blood. After repeated dosing, the study observed changes in selected biomarkers, including plasma nitrite, platelet mitochondrial enzyme activity, and follistatin measures. No adverse effects attributed to (−)-epicatechin were reported in this small short-term study.
What this means in real life: This study helps distinguish purified (−)-epicatechin from cocoa, dark chocolate, or mixed flavanol products. It shows that purified (−)-epicatechin can be absorbed and measured in humans, and that it may influence biological pathways connected to nitric oxide signaling, vascular biology, mitochondrial enzyme activity, and muscle-related signaling.
These findings are preliminary. The study did not test whether (−)-epicatechin improves fatigue, exercise performance, recovery, cardiovascular outcomes, or any disease condition. Larger and longer clinical trials would be needed to evaluate those questions.
Clinical Relevance: Human phase I pharmacokinetic and partial pharmacodynamic study in healthy volunteers; purified (−)-epicatechin, nitric oxide metabolites, platelet mitochondrial enzyme activity, and follistatin signaling; not a randomized efficacy trial and not evidence that (−)-epicatechin treats, prevents, or cures disease.
Related Content:
- For a deeper look at epicatechin and mitochondrial support → Mitozz, (-)-Epicatechin and “Mitochondrial Support”
- For a practical explanation of endothelial function and vascular health → 8 Simple Everyday Habits That Help Keep Your Arteries Healthy
- For a broader explanation of mitochondrial renewal → Mitochondrial Biogenesis and Mitophagy: Build More, Clear Better
Mitochondrial Transfer and Peripheral Neuropathy
Study Title: Mitochondrial transfer from glia to neurons protects against peripheral neuropathy
Citation: Xu et al., 2026 · Nature
What the Study Found: This study investigated how satellite glial cells in dorsal root ganglia support sensory neurons. The authors found that these glial cells can transfer mitochondria to sensory neurons through tunnelling nanotube-like structures, a process involving the protein MYO10. In mouse and human tissue, the researchers observed structural evidence of these glia-neuron connections. Blocking mitochondrial transfer in mice led to nerve degeneration and neuropathic pain-like behavior, while transfer of human satellite glial cells into mouse dorsal root ganglia provided MYO10-dependent protection against peripheral neuropathy. The findings suggest that mitochondrial sharing between glia and neurons may be an important protective mechanism in peripheral nerve biology.
What this means in real life: Nerve cells have high energy demands, especially sensory neurons with long axons that must maintain function far from the cell body. This study suggests that neurons may not rely only on their own mitochondria. Nearby glial support cells may help maintain neuronal energy capacity by donating mitochondria when needed. That does not mean mitochondrial transfer is a proven treatment for neuropathy in humans, but it expands the way we think about nerve health, showing that cellular energy support can depend on cooperation between different cell types.
Clinical Relevance: Translational study using mouse models, human dorsal root ganglion tissue, diabetic neuropathy context, mitochondrial transfer biology, and neuropathic pain mechanisms; not a human clinical trial.
Related Content:
- For a practical explanation of cellular energy and recovery → What Does “Mitochondrial Dysfunction” Actually Feel Like?
- For a broader look at low energy and cellular capacity → Why Am I Always Tired?
- For the timeline of building mitochondrial capacity → How Long Does It Take to Improve My Mitochondria? A Realistic Timeline for Beginners